Skip to content

To evaluate the efficacy of yatimadhu ksheer basti and yastimadhu churna in management of amlapitta w.s.r to hyperchlorhydria

A Comparative clinical study to evaluate the efficacy of yastimadhu Ksheer Basti and yastimadhu churna in management of amlapitta w.s.r to hyperchlorhydria - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105772
Enrollment
40
Registered
2026-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

Dr. Najnin Begum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as Amlapitta according to Ayurvedic classical features like Avipaka, Klama, Utklesha,Tikta-Amla-udgara, Gourava, Hrit-kanda-daha and Aruchi will be randomly selected irrespective of sex, religion and occupation Symptoms of hyperchlorhydria like heart and chest burn,throat burn,pungent-sour eructation,nausea,vomiting,indigestion,headache,fatigue etc

Exclusion criteria

Exclusion criteria: Lactating and pregnant women Patient suffering from other systemic illness which may interfere with course of treatment.

Design outcomes

Primary

MeasureTime frame
change in time and symptoms of amlapitta avipaak klama utklesha Tikta-amla udhgar Guruta Hrit-kantha daha AruchiTimepoint: 30 days

Secondary

MeasureTime frame
serological test for antibodies to H.pylori(if needed) blood test for TLC,DLC,HB%,ESR. LFT,KFT(if needed) Endoscopy(if needed) USG whole abdomen(if needed)Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Prof Satyendra Kumar Tiwari

Department of panchakarma Government Ayurvedic College and Hospital Patna

Satyendratiwari.25@gmail.com9024064735

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026